GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Elicera Therapeutics ELIC.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

2.58

-0.77%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

—

FY2016FY2025

Net income

−SEK 17.4m

FY2016FY2025

Free cash flow

−SEK 21.6m

FY2016FY2025

Shareholders' equity

SEK 23.4m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue—SEK 7.1mSEK 11.2mSEK 1.3mSEK 587—————
Gross profit—SEK 7.1mSEK 11.2mSEK 1.3m−SEK 11,189−SEK 11,776————
Operating income−SEK 17.9m−SEK 16.9m−SEK 28.3m−SEK 19.4m−SEK 13.1m−SEK 2.8m−SEK 194,250−SEK 3,520−SEK 3,655−SEK 4,395
Net income−SEK 17.4m−SEK 16.1m−SEK 16.4m−SEK 19.5m−SEK 13.1m−SEK 2.8m−SEK 187,876−SEK 3,525−SEK 4,958−SEK 4,823
Diluted earnings per share-0.36-0.43-0.83-0.99-0.66-0.15-0.00-0.00-0.00-0.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 27.4mSEK 27.6mSEK 30.2mSEK 46.3mSEK 54.7mSEK 12.6mSEK 618,101SEK 809,164SEK 812,689SEK 938,247
Cash and short-term investmentsSEK 24.8mSEK 26.4mSEK 29.4mSEK 43.8mSEK 52.4mSEK 11.6mSEK 33,828SEK 56,174SEK 810,580SEK 924,964
Total liabilitiesSEK 4.1mSEK 6.8mSEK 13.8mSEK 13.5mSEK 2.5mSEK 2.4mSEK 4,000SEK 4,000SEK 4,000SEK 124,600
Shareholders' equitySEK 23.4mSEK 20.8mSEK 16.4mSEK 32.8mSEK 52.2mSEK 10.2mSEK 614,101SEK 805,164SEK 808,689SEK 813,647
Shares outstanding49m37m20m20m20m19m53m53m53m53m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−SEK 21.6m−SEK 23.5m−SEK 14.9m−SEK 8.6m−SEK 14.3m−SEK 905,251−SEK 239,159−SEK 239,159−SEK 239,159—
Capital spending−SEK 4—−SEK 1,000——−SEK 58,880————
Free cash flow−SEK 21.6m−SEK 23.5m−SEK 14.9m−SEK 8.6m−SEK 14.3m−SEK 964,131−SEK 239,159−SEK 239,159−SEK 239,159—

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue−SEK 147,656———SEK 2.7mSEK 218,862SEK 2.9mSEK 233,633
Gross profit−SEK 147,656———SEK 2.7mSEK 218,862SEK 2.9mSEK 233,633
Operating income−SEK 6.3m−SEK 5.1m−SEK 7.1mSEK 146,689−SEK 2.9m−SEK 8.1m−SEK 2.9m−SEK 2.7m
Net income−SEK 6.3m−SEK 5.1m−SEK 7.0mSEK 304,153−SEK 2.7m−SEK 8.0m−SEK 2.6m−SEK 2.5m
Diluted earnings per share-0.12-0.09-0.140.01-0.06-0.17-0.07-0.07
Cash from operations−SEK 3.0m−SEK 6.0m−SEK 10.0m−SEK 4.0m−SEK 5.0m—−SEK 4.0m−SEK 2.0m
Total assetsSEK 59.6mSEK 20.9mSEK 27.4mSEK 37.3mSEK 40.9mSEK 46.4mSEK 27.6mSEK 31.1m
Cash and short-term investmentsSEK 58.1mSEK 17.9mSEK 24.8mSEK 34.9mSEK 39.7mSEK 45.7mSEK 26.4mSEK 30.6m
Shareholders' equitySEK 56.3mSEK 18.3mSEK 23.4mSEK 30.3mSEK 30.0mSEK 32.8mSEK 20.8mSEK 23.4m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-2.5%44.7%—
Net income-3.7%43.9%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings-14.6-3.9-2.0-1.3-2.7
Price to sales—8.72.919.5—

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.